title: Elaboration and "in vitro" characterization of 5-ASA beads.
abstract: The purpose of this research was to perform the design and in vitro evaluation of alginate beads containing 5-ASA in order to achieve an oral system that protects the drug until it reaches the colon. Alginate beads were prepared by the well-known ionic gelation reaction (Ca2+). The influence of the incorporation of several polymers (Eudragit FS 30D, Eudragit S100, and chitosan) in the initial formulation was studied. In all formulations, entrapment efficiencies of the drug higher than 70% were obtained. The scanning electron microscopy (SEM) study of beads showed homogeneous sizes and shapes in all cases. Finally, the release behavior of these polymeric beads were also studied and compared. The results indicated that Eudragit FS 30D (26%) showed the most favorable dissolution behavior in terms of achieving a controlled release of 5-ASA. To determine the mechanism of drug release from these beads, the Korsmeyer equation was applied. Qt/Qinfinity <0.9 can be described using a Higuchi model and Qt/Qinfinity=0.7 showed a zero-order release period. This formulation was assayed at other different pH values (pH=6; 6.8; 7.2) to assure that there is no release of 5-ASA until the system reaches the colon. No release was observed at pH 6.0. Release was very slow at pH 6.8; averages about 20% an hour at pH 7.2 and was complete within 4 hour at pH 7.4. So, these Eudragit FS beads exhibited interesting dissolution profiles for the therapy of colon pathologies.
authors.affiliation: Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. holgado@us.es
authors.forename: A
authors.initials: A
authors.lastname: Iruín
authors.forename: M
authors.initials: M
authors.lastname: Fernández-Arévalo
authors.forename: J
authors.initials: J
authors.lastname: Alvarez-Fuéntes
authors.forename: A
authors.initials: A
authors.lastname: Fini
authors.forename: M A
authors.initials: MA
authors.lastname: Holgado
mesh_terms: D000284:Administration, Oral; D000464:Alginates / Q000737:chemistry*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000032:analysis* / Q000737:chemistry*; D001672:Biocompatible Materials / Q000737:chemistry*; D002138:Calibration; D003106:Colon; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D020723:Glucuronic Acid / Q000737:chemistry*; D006603:Hexuronic Acids / Q000737:chemistry*; D006801:Humans; D019804:Mesalamine / Q000032:analysis* / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D008863:Microspheres; D012995:Solubility
chemical_list: D000464:Alginates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D006603:Hexuronic Acids; D019804:Mesalamine; D020723:Glucuronic Acid